Vascular endothelial growth factor-B: Impact on physiology and pathology

References

• Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009;21:154-65. doi:10.1016/j.ceb.2008.12.012. PMID:19230644
   PubMed Web of Science ®Google Scholar
• Leonard P, Scotney PD, Jabeen T, Iyer S, Fabri LJ, Nash AD, Acharya KR. Crystal structure of vascular endothelial growth factor-B in complex with a neutralising antibody Fab fragment. J Mol Biol. 2008;384:1203-17. doi:10.1016/j.jmb.2008.09.076. PMID:18930733
   PubMed Web of Science ®Google Scholar
• Stuttfeld E, Ballmer-Hofer K. Structure and function of VEGF receptors. IUBMB Life. 2009;61:915-22. doi:10.1002/iub.234. PMID:19658168
   PubMed Web of Science ®Google Scholar
• Neufeld G, Kessler O, Herzog Y. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. Adv Exp Med Biol. 2002;515:81-90. doi:10.1007/978-1-4615-0119-0_7. PMID:12613545
   PubMed Web of Science ®Google Scholar
• Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994;269:25646-54. PMID:7929268
   PubMed Web of Science ®Google Scholar
• Albrecht I, Kopfstein L, Strittmatter K, Schomber T, Falkevall A, Hagberg CE, Lorentz P, Jeltsch M, Alitalo K, Eriksson U, et al. Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis. PLoS One. 2010;5:e14109. doi:10.1371/journal.pone.0014109. PMID:21124841
   PubMed Web of Science ®Google Scholar
• During MJ, Liu X, Huang W, Magee D, Slater A, McMurphy T, Wang C, Cao L. Adipose VEGF Links the White-to-Brown Fat Switch With Environmental, Genetic, and Pharmacological Stimuli in Male Mice. Endocrinology. 2015;156:2059-73. doi:10.1210/en.2014-1905. PMID:25763639
   PubMed Web of Science ®Google Scholar
• Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 1996;93:2576-81. doi:10.1073/pnas.93.6.2576. PMID:8637916
   PubMed Web of Science ®Google Scholar
• Li X, Kumar A, Zhang F, Lee C, Tang Z. Complicated life, complicated VEGF-B. Trends Mol Med. 2012;18:119-27. doi:10.1016/j.molmed.2011.11.006. PMID:22178229
   PubMed Web of Science ®Google Scholar
• Scotney PD, MacKenzie A, Maccarone P, Fabri LJ, Scrofani SD, Gooley PR, Nash AD. Human vascular endothelial growth factor B: characterization of recombinant isoforms and generation of neutralizing monoclonal antibodies. Clin Exp Pharmacol Physiol. 2002;29:1024-9. doi:10.1046/j.1440-1681.2002.03769.x. PMID:12366396
   PubMed Web of Science ®Google Scholar
• Olofsson B, Pajusola K, von Euler G, Chilov D, Alitalo K, Eriksson U. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem 1996;271:19310-7. doi:10.1074/jbc.271.32.19310. PMID:8702615
   PubMed Web of Science ®Google Scholar
• Aase K, Lymboussaki A, Kaipainen A, Olofsson B, Alitalo K, Eriksson U. Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature. Dev Dyn. 1999;215:12-25. doi:10.1002/(SICI)1097-0177(199905)215:1<12::AID-DVDY3>3.0.CO;2-N. PMID:10340753
   PubMed Web of Science ®Google Scholar
• Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, van Meeteren LA, Samen E, Lu L, Vanwildemeersch M, et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature. 2010;464:917-21. doi:10.1038/nature08945. PMID:20228789
   PubMed Web of Science ®Google Scholar
• Nash AD, Baca M, Wright C, Scotney PD. The biology of vascular endothelial growth factor-B (VEGF-B). Pulm Pharmacol Ther. 2006;19:61-9. doi:10.1016/j.pupt.2005.02.007. PMID:16286239
   PubMed Web of Science ®Google Scholar
• Karpanen T, Bry M, Ollila HM, Seppanen-Laakso T, Liimatta E, Leskinen H, Kivelä R, Helkamaa T, Merentie M, Jeltsch M, et al. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res. 2008;103:1018-26. doi:10.1161/CIRCRESAHA.108.178459. PMID:18757827
   PubMed Web of Science ®Google Scholar
• Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholová I, Kauppinen RA, Achen MG, Stacker SA, et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res. 2003;92:1098-106. doi:10.1161/01.RES.0000073584.46059.E3. PMID:12714562
   PubMed Web of Science ®Google Scholar
• Reichelt M, Shi S, Hayes M, Kay G, Batch J, Gole GA, Browning J. Vascular endothelial growth factor-B and retinal vascular development in the mouse. Clin Exp Ophthalmol. 2003;31:61-5. doi:10.1046/j.1442-9071.2003.00602.x. PMID:12580897
   PubMed Web of Science ®Google Scholar
• Li X, Tjwa M, Van Hove I, Enholm B, Neven E, Paavonen K, Jeltsch M, Juan TD, Sievers RE, Chorianopoulos E, et al. Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler Thromb Vasc Biol. 2008;28:1614-20. doi:10.1161/ATVBAHA.107.158725. PMID:18511699
   PubMed Web of Science ®Google Scholar
• Zhong XF, Huang H, Shen JK, Zacchigna S, Zentilin L, Giacca M, Vinores SA. Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation. Mol Vis. 2011;17:492-507. PMID:21364963
   PubMed Web of Science ®Google Scholar
• Claesson-Welsh L. VEGF-B Taken to Our Hearts Specific Effect of VEGF-B in Myocardial Ischemia. Arterioscl Throm Vas. 2008;28:1575-6. doi:10.1161/ATVBAHA.108.170878.
   Google Scholar
• Li Y, Zhang F, Nagai N, Tang Z, Zhang S, Scotney P, Lennartsson J, Zhu C, Qu Y, Fang C, et al. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest. 2008;118:913-23. PMID:18259607
   PubMed Web of Science ®Google Scholar
• Poesen K, Lambrechts D, Van Damme P, Dhondt J, Bender F, Frank N, Bogaert E, Claes B, Heylen L, Verheyen A, et al. Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci. 2008;28:10451-9. doi:10.1523/JNEUROSCI.1092-08.2008. PMID:18923022
   PubMed Web of Science ®Google Scholar
• Eichmann A, Makinen T, Alitalo K. Neural guidance molecules regulate vascular remodeling and vessel navigation. Genes Dev. 2005;19:1013-21. doi:10.1101/gad.1305405. PMID:15879551
   PubMed Web of Science ®Google Scholar
• Li X, Lee C, Tang Z, Zhang F, Arjunan P, Li Y, Hou X, Kumar A, Dong L. VEGF-B: a survival, or an angiogenic factor? Cell Adh Migr. 2009;3:322-7. doi:10.4161/cam.3.4.9459. PMID:19684473
   PubMed Web of Science ®Google Scholar
• Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell. 2012;148:1160-71. doi:10.1016/j.cell.2012.02.010. PMID:22424227
   PubMed Web of Science ®Google Scholar
• A DR. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1998;37:667-87.
   Google Scholar
• Bergman RN. Minimal model: perspective from 2005. Horm Res. 2005;64 Suppl 3:8-15. PMID:16439839
   PubMedGoogle Scholar
• Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506-14. doi:10.1007/s00125-011-2204-7. PMID:21656330
   PubMed Web of Science ®Google Scholar
• Phielix E, Meex R, Ouwens DM, Sparks L, Hoeks J, Schaart G, Moonen-Kornips E, Hesselink MK, Schrauwen P. High oxidative capacity due to chronic exercise training attenuates lipid-induced insulin resistance. Diabetes. 2012;61:2472-8. doi:10.2337/db11-1832. PMID:22787138
   PubMed Web of Science ®Google Scholar
• Deacon CF, Carr RD, Holst JJ. DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes. Front Biosci. 2008;13:1780-94. doi:10.2741/2799. PMID:17981667
   PubMed Web of Science ®Google Scholar
• Group EDP. A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med. 1999;16:716-30. PMID:10510947
   PubMedGoogle Scholar
• Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-9. doi:10.1016/S0140-6736(63)91500-9. PMID:13990765
   PubMed Web of Science ®Google Scholar
• Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375:2267-77. doi:10.1016/S0140-6736(10)60408-4. PMID:20609972
   PubMed Web of Science ®Google Scholar
• Turinsky J, O'Sullivan DM, Bayly BP. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem. 1990;265:16880-5. PMID:2211599
   PubMed Web of Science ®Google Scholar
• Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002;277: 50230-6. doi:10.1074/jbc.M200958200. PMID:12006582
   PubMed Web of Science ®Google Scholar
• Teruel T, Hernandez R, Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes. 2001;50:2563-71. doi:10.2337/diabetes.50.11.2563. PMID:11679435
   PubMed Web of Science ®Google Scholar
• Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-6. doi:10.1007/s001250051123. PMID:10027589
   PubMed Web of Science ®Google Scholar
• Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852-71. doi:10.1016/j.cell.2012.02.017. PMID:22385956
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-801. doi:10.1172/JCI29069. PMID:16823477
   PubMed Web of Science ®Google Scholar
• Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA, Matsuhisa M, Yamasaki Y. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int J Biochem Cell Biol. 2006;38:782-93. doi:10.1016/j.biocel.2006.01.004. PMID:16607699
   PubMed Web of Science ®Google Scholar
• Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 2007;117:2621-37. doi:10.1172/JCI31021. PMID:17717599
   PubMed Web of Science ®Google Scholar
• Stefanovski D, Richey JM, Woolcott O, Lottati M, Zheng D, Harrison LN, Ionut V, Kim SP, Hsu I, Bergman RN. Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA. PLoS One. 2011;6:e18134. doi:10.1371/journal.pone.0018134. PMID:21479217
   PubMed Web of Science ®Google Scholar
• Hoppa MB, Collins S, Ramracheya R, Hodson L, Amisten S, Zhang Q, Johnson P, Ashcroft FM, Rorsman P. Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca(2+) channels from secretory granules. Cell Metab. 2009;10:455-65. doi:10.1016/j.cmet.2009.09.011. PMID:19945403
   PubMed Web of Science ®Google Scholar
• Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, Schindhelm RK, Mari A, Heine RJ, Diamant M. Pancreatic fat content and β-cell function in men with and without type 2 diabetes. Diabetes care. 2007;30:2916-21. doi:10.2337/dc07-0326. PMID:17666465
   PubMed Web of Science ®Google Scholar
• Collins SC, Hoppa MB, Walker JN, Amisten S, Abdulkader F, Bengtsson M, Fearnside J, Ramracheya R, Toye AA, Zhang Q, et al. Progression of diet-induced diabetes in C57BL6J mice involves functional dissociation of Ca2(+) channels from secretory vesicles. Diabetes. 2010;59:1192-201. doi:10.2337/db09-0791. PMID:20150285
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Wong BW, De Bock K. Treating diabetes by blocking a vascular growth factor. Cell Metab. 2012;16:553-5. doi:10.1016/j.cmet.2012.10.015. PMID:23140637
   PubMed Web of Science ®Google Scholar
• Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A. 2007;104:12587-94. doi:10.1073/pnas.0705408104. PMID:17640906
   PubMed Web of Science ®Google Scholar
• Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65:1096-108. doi:10.1016/j.metabol.2016.01.001. PMID:26856933
   PubMed Web of Science ®Google Scholar
• Berger JP, Akiyama TE, Meinke PT. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci. 2005;26:244-51. doi:10.1016/j.tips.2005.03.003. PMID:15860371
   PubMed Web of Science ®Google Scholar
• Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994;331:1188-93. doi:10.1056/NEJM199411033311803. PMID:7935656
   PubMed Web of Science ®Google Scholar
• Yang X, Smith U. Adipose tissue distribution and risk of metabolic disease: Does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 2007;50(6):1127-39. doi: 10.1007/s00125-007-0640-1. PMID: 17393135
   PubMedGoogle Scholar
• Lehrke M, Lazar MA. The many faces of PPARgamma. Cell. 2005;123:993-9. doi:10.1016/j.cell.2005.11.026. PMID:16360030
   PubMed Web of Science ®Google Scholar
• Mehrotra D, Wu J, Papangeli I, Chun HJ. Endothelium as a gatekeeper of fatty acid transport. Trends Endocrin Met. 2014;25:99-106. doi:10.1016/j.tem.2013.11.001.
   PubMed Web of Science ®Google Scholar
• Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356:2457-71. doi:10.1056/NEJMoa072761. PMID:17517853
   PubMed Web of Science ®Google Scholar
• Miller CP. SERMs: evolutionary chemistry, revolutionary biology. Curr Pharm Des. 2002;8:2089-111. doi:10.2174/1381612023393404. PMID:12171520
   PubMed Web of Science ®Google Scholar
• Hegarty BD, Furler SM, Oakes ND, Kraegen EW, Cooney GJ. Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo—a study using the novel PPARα/γ agonist tesaglitazar. Endocrinology. 2004;145:3158-64. doi:10.1210/en.2004-0260. PMID:15059948
   PubMed Web of Science ®Google Scholar
• Hagberg C, Mehlem A, Falkevall A, Muhl L, Eriksson U. Endothelial fatty acid transport: role of vascular endothelial growth factor B. Physiology (Bethesda). 2013;28:125-34. doi:10.1152/physiol.00042.2012. PMID:23455771
   PubMed Web of Science ®Google Scholar
• Mehlem A, Palombo I, Wang X, Hagberg CE, Eriksson U, Falkevall A. PGC-1alpha Coordinates Mitochondrial Respiratory Capacity and Muscular Fatty Acid Uptake via Regulation of VEGF-B. Diabetes. 2016;65:861-73. doi:10.2337/db15-1231. PMID:26822083
   PubMed Web of Science ®Google Scholar
• Li X. VEGF-B: a thing of beauty. Cell Res. 2010;20:741-4. doi:10.1038/cr.2010.77. PMID:20531376
   PubMed Web of Science ®Google Scholar
• Muoio DM, Koves TR. Lipid-induced metabolic dysfunction in skeletal muscle. Novartis Found Symp 2007; 286:24-38; discussion-46, 162-3, 96-203. doi: 10.1002/9780470985571.ch4. PMID:18269172
   PubMedGoogle Scholar
• Hagberg CE, Mehlem A, Falkevall A, Muhl L, Fam BC, Ortsater H, Scotney P, Nyqvist D, Samén E, Lu L, et al. Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature. 2012;490:426-30. doi:10.1038/nature11464. PMID:23023133
   PubMed Web of Science ®Google Scholar
• Sun CY, Lee CC, Hsieh MF, Chen CH, Chou KM. Clinical association of circulating VEGF-B levels with hyperlipidemia and target organ damage in type 2 diabetic patients. J Biol Regul Homeost Agents. 2014;28:225-36. PMID:25001655
   PubMed Web of Science ®Google Scholar
• Muhl L, Moessinger C, Adzemovic MZ, Dijkstra MH, Nilsson I, Zeitelhofer M, Hagberg CE, Huusko J, Falkevall A, Ylä-Herttuala S, et al. Expression of vascular endothelial growth factor (VEGF)-B and its receptor (VEGFR1) in murine heart, lung and kidney. Cell Tissue Res. 2016;365:51-63. doi:10.1007/s00441-016-2377-y. PMID:26928042
   PubMed Web of Science ®Google Scholar
• Robciuc MR, Kivela R, Williams IM, de Boer JF, van Dijk TH, Elamaa H, Tigistu-Sahle F, Molotkov D, Leppänen VM, Käkelä R, et al. VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications. Cell Metab. 2016;23:712-24. doi:10.1016/j.cmet.2016.03.004. PMID:27076080
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tong Y, Gao M, Luo C, Song X, Gao X, Yao W. Expression, purification and characterization of a vascular endothelial growth factor fusion protein. Biotechnol Lett. 2016;38:1115-20. doi:10.1007/s10529-016-2081-8. PMID:26976430
   PubMed Web of Science ®Google Scholar
• Lagercrantz J, Larsson C, Grimmond S, Fredriksson M, Weber G, Piehl F. Expression of the VEGF-related factor gene in pre- and postnatal mouse. Biochem Biophys Res Commun. 1996;220:147-52. doi:10.1006/bbrc.1996.0372. PMID:8602835
   PubMed Web of Science ®Google Scholar
• Bellomo D, Headrick JP, Silins GU, Paterson CA, Thomas PS, Gartside M, Mould A, Cahill MM, Tonks ID, Grimmond SM, et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res. 2000;86:e29−e35. doi:10.1161/01.RES.86.2.e29. PMID:10666423
   PubMed Web of Science ®Google Scholar
• Lagercrantz J, Farnebo F, Larsson C, Tvrdik T, Weber G, Piehl F. A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse. Biochim Biophys Acta 1998;1398:157-63. doi:10.1016/S0167-4781(98)00040-2. PMID:9689915
   PubMed Web of Science ®Google Scholar
• Hew KW, Keller KA. Postnatal anatomical and functional development of the heart: a species comparison. Birth Defects Res B Dev Reprod Toxicol. 2003;68:309-20. doi:10.1002/bdrb.10034. PMID:14666994
   PubMed Web of Science ®Google Scholar
• Kivela R, Bry M, Robciuc MR, Rasanen M, Taavitsainen M, Silvola JM, Saraste A, Hulmi JJ, Anisimov A, Mäyränpää MI, et al. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. EMBO Mol Med. 2014;6:307-21. PMID:24448490
   PubMed Web of Science ®Google Scholar
• Aase K, von Euler G, Li X, Ponten A, Thoren P, Cao R, Cao Y, Olofsson B, Gebre-Medhin S, Pekny M, et al. Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect. Circulation. 2001;104:358-64. doi:10.1161/01.CIR.104.3.358. PMID:11457758
   PubMed Web of Science ®Google Scholar
• Kupatt C, Hinkel R. VEGF-B: a more balanced approach toward cardiac neovascularization? EMBO Mol Med. 2014;6:297-8. doi:10.1002/emmm.201303730. PMID:24521742
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med. 2003;9:694-701. doi:10.1038/nm0603-694. PMID:12778168
   PubMed Web of Science ®Google Scholar
• Serpi R, Tolonen AM, Huusko J, Rysa J, Tenhunen O, Yla-Herttuala S, Ruskoaho H. Vascular endothelial growth factor-B gene transfer prevents angiotensin II-induced diastolic dysfunction via proliferation and capillary dilatation in rats. Cardiovasc Res. 2011;89:204-13. doi:10.1093/cvr/cvq267. PMID:20733007
   PubMed Web of Science ®Google Scholar
• Bry M, Kivela R, Holopainen T, Anisimov A, Tammela T, Soronen J, Silvola J, Saraste A, Jeltsch M, Korpisalo P, et al. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation. 2010;122:1725-33. doi:10.1161/CIRCULATIONAHA.110.957332. PMID:20937974
   PubMed Web of Science ®Google Scholar
• Zentilin L, Puligadda U, Lionetti V, Zacchigna S, Collesi C, Pattarini L, Ruozi G, Camporesi S, Sinagra G, Pepe M, et al. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J. 2010;24:1467-78. doi:10.1096/fj.09-143180. PMID:20019242
   PubMed Web of Science ®Google Scholar
• Lähteenvuo JE, Lähteenvuo MT, Kivelä A, Rosenlew C, Falkevall A, Klar J, Heikura T, Rissanen TT, Vähäkangas E, Korpisalo P, et al. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1–and neuropilin receptor-1–dependent mechanisms. Circulation. 2009;119:845-56. doi:10.1161/CIRCULATIONAHA.108.816454. PMID:19188502
   PubMed Web of Science ®Google Scholar
• Dijkstra MH, Pirinen E, Huusko J, Kivela R, Schenkwein D, Alitalo K, Ylä-Herttuala S. Lack of cardiac and high-fat diet induced metabolic phenotypes in two independent strains of Vegf-b knockout mice. Sci Rep. 2014;4:6238. doi:10.1038/srep06238. PMID:25168313
   PubMed Web of Science ®Google Scholar
• Huusko J, Merentie M, Dijkstra MH, Ryhanen MM, Karvinen H, Rissanen TT, Vanwildemeersch M, Hedman M, Lipponen J, Heinonen SE, et al. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice. Cardiovasc Res. 2010;86:122-30. doi:10.1093/cvr/cvp382. PMID:19955220
   PubMed Web of Science ®Google Scholar
• Vogt AM, Elsässer A, Nef H, Bode C, Kübler W, Schaper J. Increased glycolysis as protective adaptation of energy depleted, degenerating human hibernating myocardium. Mol Cell Biochem. 2003;242:101-7. doi:10.1023/A:1021141812947. PMID:12619871
   PubMed Web of Science ®Google Scholar
• McLean BA, Kienesberger PC, Wang W, Masson G, Zhabyeyev P, Dyck JR, Oudit GY. Enhanced recovery from ischemia-reperfusion injury in PI3Kalpha dominant negative hearts: investigating the role of alternate PI3K isoforms, increased glucose oxidation and MAPK signaling. J Mol Cell Cardiol. 2013;54:9-18. doi:10.1016/j.yjmcc.2012.10.015. PMID:23142539
   PubMed Web of Science ®Google Scholar
• Eelen G, de Zeeuw P, Simons M, Carmeliet P. Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 2015;116:1231-44. doi:10.1161/CIRCRESAHA.116.302855. PMID:25814684
   PubMed Web of Science ®Google Scholar
• Li GH, Luo B, Lv YX, Zheng F, Wang L, Wei MX, Li XY, Zhang L, Wang JN, Chen SY, et al. Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury. J Transl Med. 2016;14:116. doi:10.1186/s12967-016-0847-3. PMID:27146579
   PubMed Web of Science ®Google Scholar
• Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005;115:2108-18. doi:10.1172/JCI24682. PMID:16075055
   PubMed Web of Science ®Google Scholar
• Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest. 2001;107:813-22. doi:10.1172/JCI10947. PMID:11285300
   PubMed Web of Science ®Google Scholar
• Digel M, Staffer S, Ehehalt F, Stremmel W, Ehehalt R, Füllekrug J. FATP4 contributes as an enzyme to the basal and insulin-mediated fatty acid uptake of Cx2C12 muscle cells. Am J Physiol-Endoc M. 2011;301:E785-E96.
   PubMed Web of Science ®Google Scholar
• Bhardwaj S, Roy H, Gruchala M, Viita H, Kholova I, Kokina I, Achen MG, Stacker SA, Hedman M, Alitalo K, et al. Angiogenic responses of vascular endothelial growth factors in periadventitial tissue. Hum Gene Ther. 2003;14:1451-62. doi:10.1089/104303403769211664. PMID:14577925
   PubMed Web of Science ®Google Scholar
• Mould AW, Greco SA, Cahill MM, Tonks ID, Bellomo D, Patterson C, Zournazi A, Nash A, Scotney P, Hayward NK, et al. Transgenic overexpression of vascular endothelial growth factor-B isoforms by endothelial cells potentiates postnatal vessel growth in vivo and in vitro. Circ Res. 2005;97:e60−70. doi:10.1161/01.RES.0000182631.33638.77. PMID:16109918
   PubMed Web of Science ®Google Scholar
• Goren HJ, Kulkarni RN, Kahn CR. Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1. Endocrinology. 2004;145:3307-23. doi:10.1210/en.2003-1400. PMID:15044376
   PubMed Web of Science ®Google Scholar
• Rissanen TT, Yla-Herttuala S. Current status of cardiovascular gene therapy. Mol Ther. 2007;15:1233-47. doi:10.1038/sj.mt.6300175. PMID:17505481
   PubMed Web of Science ®Google Scholar
• Favre D, Provost N, Blouin V, Blancho G, Cherel Y, Salvetti A, Moullier P. Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. Mol Ther. 2001;4:559-66. doi:10.1006/mthe.2001.0494. PMID:11735340
   PubMed Web of Science ®Google Scholar
• Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 2003;10:935-40. doi:10.1038/sj.gt.3302036. PMID:12756413
   PubMed Web of Science ®Google Scholar
• Doroudgar S, Glembotski CC. The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart. Trends Mol Med. 2011;17:207-14. doi:10.1016/j.molmed.2010.12.003. PMID:21277256
   PubMed Web of Science ®Google Scholar
• Ferrarini M, Arsic N, Recchia FA, Zentilin L, Zacchigna S, Xu X, Linke A, Giacca M, Hintze TH. Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res. 2006;98:954-61. doi:10.1161/01.RES.0000217342.83731.89. PMID:16543500
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7:575-83. doi:10.1038/87904. PMID:11329059
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932-6. doi:10.1038/nature04478. PMID:16355210
   PubMed Web of Science ®Google Scholar
• Jaba IM, Zhuang ZW, Li N, Jiang Y, Martin KA, Sinusas AJ, Papademetris X, Simons M, Sessa WC, Young LH, et al. NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth. J Clin Invest. 2013;123:1718-31. doi:10.1172/JCI65112. PMID:23454748
   PubMed Web of Science ®Google Scholar
• Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res. 2007;100:158-73. doi:10.1161/01.RES.0000255691.76142.4a. PMID:17272818
   PubMed Web of Science ®Google Scholar
• Kupatt C, Hinkel R, Pfosser A, El-Aouni C, Wuchrer A, Fritz A, Globisch F, Thormann M, Horstkotte J, Lebherz C, et al. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation. J Am Coll Cardiol. 2010;56:414-22. doi:10.1016/j.jacc.2010.03.050. PMID:20650363
   PubMed Web of Science ®Google Scholar
• Falk T, Zhang S, Sherman SJ. Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease. Mol Neurodegener. 2009;4:49. doi:10.1186/1750-1326-4-49. PMID:20003314
   PubMed Web of Science ®Google Scholar
• Falk T, Yue X, Zhang S, McCourt AD, Yee BJ, Gonzalez RT, Sherman SJ. Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease. Neurosci Lett. 2011;496:43-7. doi:10.1016/j.neulet.2011.03.088. PMID:21507340
   PubMed Web of Science ®Google Scholar
• Yue X, Hariri DJ, Caballero B, Zhang S, Bartlett MJ, Kaut O, Mount DW, Wüllner U, Sherman SJ, Falk T. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease. Neuroscience. 2014;258:385-400. doi:10.1016/j.neuroscience.2013.11.038. PMID:24291725
   PubMed Web of Science ®Google Scholar
• Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111:1843-51. doi:10.1172/JCI200317977. PMID:12813020
   PubMed Web of Science ®Google Scholar
• Eggert A, Ikegaki N, Kwiatkowski J, Zhao HQ, Brodeur GM, Himelstein BP. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res. 2000;6:1900-8. PMID:10815914
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang Y, Hosaka K, Andersson P, Wang J, Tholander F, Cao Z, Morikawa H, Tegnér J, Yang Y, et al. VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patients. Proc Natl Acad Sci U S A. 2015;112:E2900−9. doi:10.1073/pnas.1503500112. PMID:25991856
   PubMed Web of Science ®Google Scholar
• Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9:225-30; discussion 31. doi:10.1007/s10456-006-9055-8. PMID:17109193
   PubMedGoogle Scholar
• Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995;376:66-70. doi:10.1038/376066a0. PMID:7596436
   PubMed Web of Science ®Google Scholar
• Kanda M, Nomoto S, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. J Surg Oncol. 2008;98:190-6. doi:10.1002/jso.21095. PMID:18537151
   PubMed Web of Science ®Google Scholar
• Lautenschlaeger T, George A, Klimowicz AC, Efstathiou JA, Wu CL, Sandler H, Shipley WU, Tester WJ, Hagan MP, Magliocco AM, et al. Bladder preservation therapy for muscle-invading bladder cancers on Radiation Therapy Oncology Group trials 8802, 8903, 9506, and 9706: vascular endothelial growth factor B overexpression predicts for increased distant metastasis and shorter survival. Oncologist. 2013;18:685-6.
   PubMed Web of Science ®Google Scholar
• Zhu M, Zhang Q, Wang X, Kang L, Yang Y, Liu Y, et al. Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway. Oncotarget 2016.7(51):84190-200. doi:10.18632/oncotarget.12391. PMID:27705937
   PubMedGoogle Scholar
• Scrofani SD, Fabri LJ, Xu P, Maccarone P, Nash AD. Purification and refolding of vascular endothelial growth factor-B. Protein Sci. 2000;9:2018-25. doi:10.1110/ps.9.10.2018. PMID:11106176
   PubMed Web of Science ®Google Scholar
• Yu L, Liang XH, Ferrara N. Comparing protein VEGF inhibitors: In vitro biological studies. Biochem Biophys Res Commun. 2011;408:276-81. doi:10.1016/j.bbrc.2011.04.014. PMID:21501594
   PubMed Web of Science ®Google Scholar
• Gerber HP, Wu X, Yu L, Wiesmann C, Liang XH, Lee CV, Fuh G, Olsson C, Damico L, Xie D, et al. Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies. Proc Natl Acad Sci U S A. 2007;104:3478-83. doi:10.1073/pnas.0611492104. PMID:17360669
   PubMed Web of Science ®Google Scholar
• Larsen AK, Ouaret D, El Ouadrani K, Petitprez A. Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther. 2011;131:80-90. doi:10.1016/j.pharmthera.2011.03.012. PMID:21439312
   PubMed Web of Science ®Google Scholar